CV Sciences’ PlusCBD Oil™ Used in First Study Examining Clinical Benefit of CBD for Patients with PTSD

    NEXT STORY
    Homology Medicines Announces FDA Fast Track Designation for HMI-102 Gene Therapy Development Candidate for Adults with PKU
    PREV STORY
    Sun BioPharma, Inc. Provides a Business Update and Files Report for Q1 2019
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Biohitin GastroPanel® ennusti tarkasti mahasyöpäriskiä yli 12000 henkilön aineistossa 12 vuoden seurannan aikana Kiinassa

    Biohit Oyj lehdistötiedote 16.08.2017 klo 14:45 paikallista aikaa (EEST) Kiinalainen, professori Yuan Yuanin johtama ...

    author_avatar
    NASDAQ Market News

    T2 Biosystems T2SARS-CoV-2™ Panel Proves Effective Amid Global Rise in Variants of the SARS-CoV-2 Virus

    author_avatar
    NASDAQ Market News

    Aclaris Therapeutics Announces ATI-450 (MK2 pathway Inhibitor) publication in the Journal Cancer Research

    WAYNE, Pa., Aug. 21, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led ...

    author_avatar
    NASDAQ Market News